Last year, South Korea’s exports grew for the first time ever, surpassing 700 billion dollars, but an analysis revealed that ...
Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...